Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease. - sprookjes - yvandenbroek - TriplyDB

Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.

Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.

http://www.wikidata.org/entity/Q34273978

about

Metabolic syndrome: an important risk factor for Parkinson's disease Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.Protection by inosine in a cellular model of Parkinson's disease Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices.Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study.Protection of dopaminergic cells by urate requires its accumulation in astrocytes Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration Prospective study of plasma urate and risk of Parkinson disease in men and women.Urate as a Marker of Risk and Progression of Neurodegenerative Disease.Targeting urate to reduce oxidative stress in Parkinson disease.Low serum uric acid levels in progressive supranuclear palsy.Serum urate at trial entry and ALS progression in EMPOWER.Genetic variability related to serum uric acid concentration and risk of Parkinson's disease.Metabolic Differences between Dogs of Different Body Sizes.Genome-wide variant by serum urate interaction in Parkinson's disease.Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway.Lower Serum Bilirubin and Uric Acid Concentrations in Patients with Parkinson's Disease in China.Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson's Disease Models.Wide expression of type I Na+-phosphate cotransporter 3 (NPT3/SLC17A2), a membrane potential-driven organic anion transporter.Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis ALSUntangled No. 37: Inosine*Recent Advances in Biomarkers for Parkinson's Disease

P2860

Q27023711-29A7BD6E-B450-4353-ADE6-6A4928E1C62B Q28393646-C1EC883A-A8A6-4FE3-B06D-65E1D5D7A5B7 Q30365907-B0F5D985-3E0C-42C6-A096-D70E8A5C73F3 Q33998724-83D6597F-7362-40DE-8F8F-B801003B19EC Q34423275-76A2211D-927E-43D0-8B97-E797F4C7ED5F Q34489342-4E16ED41-C363-47EA-B18E-BE247DC23789 Q34658560-903E0442-6033-4238-B662-536EE4BB881F Q36029745-FD1B8CD6-78CB-4B11-9E80-D79505DC182D Q36223240-A5D5AC0A-920B-4C8D-B02B-DA2E08442797 Q36512151-C0770C38-4D3B-43B7-BE88-4D887BCA211F Q36580376-EAE7AC0E-4EC7-43B4-A39A-D72FF217DC59 Q39044143-785EB709-DF89-4E84-858C-B41F3BC26F69 Q39379023-C06BF4EB-ABA8-4402-A08E-B1902C8C3FD4 Q40190481-30DC7BBF-8A94-4EA8-B57A-A43C89325A42 Q40563709-22F63A52-7975-4E2A-9892-2A0F48AB10C4 Q45980386-02298C30-0029-4C0B-B180-BAC81D949BCC Q46026460-8D9276A7-860C-4A51-8529-812EF5BE7979 Q48075588-48D47BBC-9A9A-4F88-AA7E-BB1AE58B241F Q48323370-E3FF8C74-AE97-414D-A1AE-3BE4C353C1F8 Q48435711-907ECB61-C1E0-4F16-8509-8150CC87744C Q49698299-BB7FAB8D-AA5F-419C-B3D0-22FDD81C9A41 Q50214009-EEA96CBB-D878-4C55-B6EC-2C0FA4B2A3C5 Q57176144-5CB9843C-FB64-4C67-BBF4-DA6BB4556DE9 Q57464278-3E7D2502-CD1C-4AAE-8C2D-271E285E33BA Q58572579-7A4D0048-8DC4-4B99-8620-7E60736AEE4A

P2860

Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.

http://www.wikidata.org/entity/Q34273978

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Urate and its transgenic deple ...... model of Parkinson's disease.

@ast

Urate and its transgenic deple ...... model of Parkinson's disease.

@en

Urate and its transgenic deple ...... model of Parkinson's disease.

@nl

type

label

Urate and its transgenic deple ...... model of Parkinson's disease.

@ast

Urate and its transgenic deple ...... model of Parkinson's disease.

@en

Urate and its transgenic deple ...... model of Parkinson's disease.

@nl

prefLabel

Urate and its transgenic deple ...... model of Parkinson's disease.

@ast

Urate and its transgenic deple ...... model of Parkinson's disease.

@en

Urate and its transgenic deple ...... model of Parkinson's disease.

@nl

P1433

Q34273978-8F993C1A-217E-456A-86E3-AA966E6D45A8

P1476

Q34273978-C493C1D7-82AE-4804-98A8-4AECE64EAD91

P2093

Q34273978-2AE5B03C-F321-412A-AAD6-4C7A3773E9DF

Q34273978-3A342069-9E93-4C96-A958-DAFD715A082B

Q34273978-87487271-A247-4DA8-BCDB-38588B695443

Q34273978-A28D1D3B-94B2-4FB6-AC9E-FC09974D0121

Q34273978-D5D375D5-4C84-4CD3-94BA-CEB790FAE346

P2860

Q34273978-0331E068-C2E5-432D-9E0A-C520B8261051

Q34273978-044401D9-D354-4401-834F-B6F6A7A84211

Q34273978-060FD43D-ECE1-49E9-BF0D-58E6238E3E7D

Q34273978-0E11FFAD-DCC1-46E6-B260-71329578F15F

Q34273978-0F2173A0-C5DE-4D12-8993-EEC8995E9939

Q34273978-1215CB3A-F0BA-4B29-A3F3-81BDCDA2C476

Q34273978-29215072-743E-4309-A24E-15437393B745

Q34273978-29AEB3AA-68FF-4379-AA54-F84A2CFD90BD

Q34273978-29F3FC60-06B2-4F1E-B84D-82F6ED155C35

Q34273978-37162FE6-57D2-41D2-9261-72EAAB6E69D0

P304

Q34273978-7AE6D39E-292D-48FA-BF2F-9AC7B7AC546C

P31

Q34273978-E7FDD9D5-7D4C-4795-808B-72052F78DF03

P356

Q34273978-0D22CEF2-CB5F-4028-B1D2-B25FDD99B76E

P407

Q34273978-27AA8D46-6A12-46F7-95C7-89ED523D04CB

P433

Q34273978-39E1A7AA-D468-45FB-8523-F2758BC90E43

P478

Q34273978-6E7BB9D7-44D5-4B67-9C9B-574DBF37E103

P50

Q34273978-CD95BFBE-1B41-4E51-A914-061EAC97F192

P577

Q34273978-ED576197-AA20-4DD2-8DF6-2049A6DE1494

P5875

Q34273978-F1BDEEE6-B18C-40D5-9252-7D6759828AEE

P698

Q34273978-F1658566-E6C5-42BB-8C15-1785A3B848E8

P921

Q34273978-8663369F-186A-4995-8FE9-4E440B146521

P932

Q34273978-D5093607-7983-4B61-9D0E-742900EB866C

P356

JOURNAL.PONE.0037331

P1433

P1476

Urate and its transgenic deple ...... model of Parkinson's disease.

@en

P2093

Cody A Desjardins

http://www.w3.org/2001/XMLSchema#string

Kui Xu

http://www.w3.org/2001/XMLSchema#string

Sara Cipriani

http://www.w3.org/2001/XMLSchema#string

Thomas C Burdett

http://www.w3.org/2001/XMLSchema#string

Yuehang Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Free radical scavenging, DNA protection, and inhibition of lipid peroxidation mediated by uric acid

Molecular identification of a renal urate anion exchanger that regulates blood urate levels

Urate oxidase: primary structure and evolutionary implications

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

Caffeine and uric acid mediate glutathione synthesis for neuroprotection

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

Sodium-dependent vitamin C transporter 2 (SVCT2) expression and activity in brain capillary endothelial cells after transient ischemia in mice

Uric acid promotes an acute inflammatory response to sterile cell death in mice

Uric acid protects against secondary damage after spinal cord injury.

P304

e37331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0037331

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Michael A Schwarzschild

P577

2012-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224980325

http://www.w3.org/2001/XMLSchema#string

P698

22606360

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3351394

http://www.w3.org/2001/XMLSchema#string